Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
How Can Access to PCSK9 Inhibitors be Improved?
Author(s):
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist for UMass Medical School Clinical Pharmacy Services, discusses potential solutions for access to cholesterol lowering drugs to improve.
Related Videos
Related Content
